CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4/A Open-market buy Former 10% Owner bought 2,040,814 shares
- 4/A Open-market buy Former 10% Owner bought 2,040,814 shares
- 4 Conversion Director acquired 0 shares (conversion)
- 4 Conversion Director acquired 2,649,572 shares (conversion)
- 4 Conversion President and CEO acquired 78,129 shares (conversion)
- 4 Conversion 10% owner acquired 4,656,173 shares (conversion)
- 4 Open-market buy 10% owner bought 2,040,814 shares
- 4 Open-market buy 10% owner bought 2,040,814 shares
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 4,656,176 shares (conversion)
- 4 Open-market buy 10% owner bought 100,000 shares at $16.00 ($1,600,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 17 of 18 · 351 filings